Table 2.

Characterization of CPT-N-PLA NC prepared by LA polymerization mediated by (BDI-EI)ZnN(TMS)₂ catalyst^a

Entrya	Name	M/I ratio	Eff (%)b	Loading (%)c	Size (nm)d	PDIe
1	CPT-N-PLA100 NC	100	>95	2.3	82	0.06
2	CPT-N-PLA50 NC	50	>95	4.6	89	0.09
3	CPT-N-PLA10 NC	10	>95	18.5	73	0.12

^aAbbreviation: NC = Nanoconjugates; M/I = monomer/initiator ratio; Eff = incorporation efficiency, the percent of initiator utilized in the initiation of LA polymerization; PDI = polydispersity derived from particle sizing using DLS. NCs are named as CPT-N-PLA_M/I.

^bthe data was based on the reversed-phase HPLC analysis of unincorporated drug.

^cthe data was based on the reversed-phase HPLC analysis of unincorporated drug.

^dcharacterized by DLS.

^echaracterized by DLS.